Zixiong Li

Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Clinical Outcomes of AFP-Negative Patients with Advanced HCC: A Propensity-Matched Analysis from a Retrospective Cohort Study.

Clinical Outcomes of AFP-Negative Patients with Advanced HCC: A Propensity-Matched Analysis from a Retrospective Cohort Study.

Journal: Journal of hepatocellular carcinoma
Published: March 28, 2025

A Novel Compound Heterozygous Mutation in TDRD9 Causes Oligozoospermia.

A Novel Compound Heterozygous Mutation in TDRD9 Causes Oligozoospermia.

Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: May 27, 2024

Prognostic analysis of systemic antitumor therapy in young patients with advanced liver cancer: A cohort study.

Prognostic analysis of systemic antitumor therapy in young patients with advanced liver cancer: A cohort study.

Journal: Oncology letters
Published: February 01, 2024

Efficacy and safety of hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and tyrosine kinase inhibitors in advanced hepatocellular carcinoma: A systematic review and meta‑analysis.

Efficacy and safety of hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and tyrosine kinase inhibitors in advanced hepatocellular carcinoma: A systematic review and meta‑analysis.

Journal: Oncology letters
Published: June 05, 2023

Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study.

Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study.

Journal: Frontiers in oncology
Published: December 12, 2021

Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective.

Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective.

Journal: Translational cancer research
Published: October 22, 2020

Clinical Outcomes and Prognosis Factors of Nivolumab Plus Chemotherapy or Multitarget Tyrosine Kinase Inhibitor in Multi-Line Therapy for Recurrent Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Analysis.

Clinical Outcomes and Prognosis Factors of Nivolumab Plus Chemotherapy or Multitarget Tyrosine Kinase Inhibitor in Multi-Line Therapy for Recurrent Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Analysis.

Journal: Frontiers in oncology
Published: May 31, 2020

A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix.

A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix.

Journal: OncoTargets and therapy
Published: April 17, 2019
Showing 1-8 of 8

Last Updated: 09/26/2026